Global cross-border business solutions provider ANDAMAN ... ANDAMAN Advisory – offering transaction advisory and strategy ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Builds on Global Intellectual Property Portfolio to Protect DNAbilize® PlatformHOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

The global skincare market is expanding at a rapid pace, expected to reach $973.13 billion by 2030, with a 7.7% compound ...

GEKA, a leader in high-precision beauty application solutions and part of medmix, will unveil its latest collection of ...

Biogen expects 2025 non-GAAP EPS of $15.25-$16.25 and a mid-single-digit decline in total revenue, primarily due to MS franchise pressures, including potential biosimilar and generic entries. Growth ...

Tilray THC50 CBD50 (25ml): A high-potency 1:1 medical cannabis extract designed for patients requiring higher cannabinoid content, offering an option for those who need stronger therapeutic effects ...

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat ...

About LP-310 LP-310 is an innovative oral rinse formulation of LP-10 (tacrolimus), developed to address OLP. Designed to provide localized therapeutic effects while minimizing systemic exposure, ...